Sickle cell disease: Difference between revisions
From IDWiki
(Imported from text file) |
No edit summary |
||
Line 1: | Line 1: | ||
− | == |
+ | ==Background== |
− | * |
+ | *Genetic mutation of the hemoglobin beta chain, most commonly an E6V substitution, causing the formation of hemoglobin S |
+ | *Most common in people with African ancestry, though also occurs in Hispanic, southern European, Middle Eastern, and Indian people |
||
+ | *Life expectancy is 20-30 years shorter |
||
− | == |
+ | == Clinical Manifestations == |
+ | * Chronic anemia |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
+ | ===Crises=== |
||
+ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
+ | |||
+ | == Diagnosis == |
||
+ | |||
+ | * Hemoglobin quantification can help to identify the type of sickle cell disease |
||
+ | ** HbS is sickle hemoglobin |
||
+ | ** HbA is normal adult hemoglobin and HbA<sub>2</sub> is the minor variant of adult hemoglobin |
||
+ | ** HbF is fetal hemoglobin |
||
+ | ** HbC is a hemoglobin variant that causes sickle cell disease when paired with HbS |
||
+ | |||
+ | {| class="wikitable" |
||
+ | !Genotype |
||
+ | !Hb (g/L) |
||
+ | !HbS (%) |
||
+ | !HbA (%) |
||
+ | !HbA<sub>2</sub> (%) |
||
+ | !HbF (%) |
||
+ | !HbC (%) |
||
+ | |- |
||
+ | |AS (trait) |
||
+ | |normal |
||
+ | |≤40 |
||
+ | |>60 |
||
+ | |<3.5 |
||
+ | |≤1 |
||
+ | | |
||
+ | |- |
||
+ | |SS |
||
+ | |60-90 |
||
+ | |>90 |
||
+ | | |
||
+ | |<3.5 |
||
+ | |<10 |
||
+ | | |
||
+ | |- |
||
+ | |Sβ<sup>0</sup>-thalassemia |
||
+ | |70-90 |
||
+ | |>80 |
||
+ | | |
||
+ | |>3.5 |
||
+ | |<20 |
||
+ | | |
||
+ | |- |
||
+ | |Sβ<sup>+</sup>-thalassemia |
||
+ | |90-120 |
||
+ | |>60 |
||
+ | |10-30 |
||
+ | |>3.5 |
||
+ | |<20 |
||
+ | | |
||
+ | |- |
||
+ | |SC |
||
+ | |90-140 |
||
+ | |50 |
||
+ | | |
||
+ | |<3.5 |
||
+ | |≤1 |
||
+ | |45 |
||
+ | |} |
||
[[Category:Hematology]] |
[[Category:Hematology]] |
Latest revision as of 08:37, 16 August 2020
Background
- Genetic mutation of the hemoglobin beta chain, most commonly an E6V substitution, causing the formation of hemoglobin S
- Most common in people with African ancestry, though also occurs in Hispanic, southern European, Middle Eastern, and Indian people
- Life expectancy is 20-30 years shorter
Clinical Manifestations
- Chronic anemia
Crises
- Four major sickle crises:
- Vasoocclusive pain crisis
- Hemolytic crisis
- Aplastic crisis (often associated with parvovirus)
- Splenic sequestration crisis
Diagnosis
- Hemoglobin quantification can help to identify the type of sickle cell disease
- HbS is sickle hemoglobin
- HbA is normal adult hemoglobin and HbA2 is the minor variant of adult hemoglobin
- HbF is fetal hemoglobin
- HbC is a hemoglobin variant that causes sickle cell disease when paired with HbS
Genotype | Hb (g/L) | HbS (%) | HbA (%) | HbA2 (%) | HbF (%) | HbC (%) |
---|---|---|---|---|---|---|
AS (trait) | normal | ≤40 | >60 | <3.5 | ≤1 | |
SS | 60-90 | >90 | <3.5 | <10 | ||
Sβ0-thalassemia | 70-90 | >80 | >3.5 | <20 | ||
Sβ+-thalassemia | 90-120 | >60 | 10-30 | >3.5 | <20 | |
SC | 90-140 | 50 | <3.5 | ≤1 | 45 |